Adage Capital Partners’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-250,000
Closed -$3.13M 760
2019
Q2
$3.13M Buy
+250,000
New +$3.53M 0.01% 648
2019
Q1
Sell
-117,339
Closed -$2.27M 737
2018
Q4
$2.27M Buy
+117,339
New +$2.58M 0.01% 660
2018
Q3
Sell
-100,000
Closed -$2.66M 759
2018
Q2
$2.66M Buy
+100,000
New +$2.72M 0.01% 684

Other funds holding STIM

Adage Capital Partners's STIM Position: Q3 2019 in Review

Adage Capital Partners sold out of Neuronetics (STIM) in Q3 2019, closing a stake of 250,000 shares — an estimated $3.13M sold.

Adage Capital Partners first reported a position in STIM in Q2 2018 and held it in 3 quarters. The position peaked at $3.13M in Q2 2019. 65 funds tracked by Wall St. Rank hold STIM as of Q3 2019.

  • Adage Capital Partners reported no remaining Neuronetics position as of Q3 2019 after selling out during the quarter.
  • Adage Capital Partners sold 250,000 Neuronetics shares in Q3 2019, an estimated $3.13M.
  • Adage Capital Partners first reported a position in Neuronetics in Q2 2018 and held it in 3 quarters.
  • Adage Capital Partners's Neuronetics position peaked at $3.13M in Q2 2019.
  • 65 funds tracked by Wall St. Rank held Neuronetics as of Q3 2019.

Based on Adage Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.